Published in Am J Phys Med Rehabil on April 01, 2015
Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med (2009) 3.33
Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol (2008) 2.81
Infrared optoelectronic volumetry, the ideal way to measure limb volume. Eur J Vasc Endovasc Surg (1996) 2.22
The problem of post-breast cancer lymphedema: impact and measurement issues. Cancer Invest (2005) 2.12
Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CMAJ (2001) 1.86
Upper-extremity volume measurements in women with lymphedema: a comparison of measurements obtained via water displacement with geometrically determined volume. Phys Ther (2002) 1.75
Differences in lymph drainage between swollen and non-swollen regions in arms with breast-cancer-related lymphoedema. Clin Sci (Lond) (2001) 1.68
Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivors. Exerc Sport Sci Rev (2010) 1.67
Estimation of total body water by bioelectrical impedance analysis. Am J Clin Nutr (1986) 1.63
Development and validation of a telephone questionnaire to characterize lymphedema in women treated for breast cancer. Phys Ther (2001) 1.52
Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology (2001) 1.50
Women's experiences of lymphedema. Oncol Nurs Forum (1997) 1.46
The grading of lymphedema in oncology clinical trials. Semin Radiat Oncol (2003) 1.32
Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial. Breast Cancer Res Treat (2011) 1.29
Changes in the Body Image and Relationship Scale following a one-year strength training trial for breast cancer survivors with or at risk for lymphedema. Breast Cancer Res Treat (2009) 1.28
Physical Activity and Lymphedema (the PAL trial): assessing the safety of progressive strength training in breast cancer survivors. Contemp Clin Trials (2009) 1.27
The standard of care for lymphedema: current concepts and physiological considerations. Lymphat Res Biol (2009) 1.27
Breast cancer treatment-related lymphedema self-care: education, practices, symptoms, and quality of life. Support Care Cancer (2011) 1.26
Factors associated with increased breast cancer-related lymphedema volume. Acta Oncol (2007) 1.08
Factors influencing breast cancer-related lymphedema volume after intensive decongestive physiotherapy. Support Care Cancer (2010) 1.05
Clinical practice guidelines for breast cancer rehabilitation: syntheses of guideline recommendations and qualitative appraisals. Cancer (2012) 1.02
Self-management of lymphedema: a systematic review of the literature from 2004 to 2011. Nurs Res (2012) 0.99
Exercise and the lymphatic system: implications for breast-cancer survivors. Sports Med (2005) 0.97
The reliability of leg circumference assessment: a comparison of spring tape measurements and optoelectronic volumetry. Vasc Med (2000) 0.95
Bioelectrical impedance for monitoring the efficacy of lymphoedema treatment programmes. Breast Cancer Res Treat (1996) 0.94
Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema. Support Care Cancer (2013) 0.90
Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial. Breast Cancer Res Treat (2011) 0.86
Clinical trials needed to evaluate compression therapy in breast cancer related lymphedema (BCRL). Proposals from an expert group. Int Angiol (2010) 0.79
Risk of myocardial infarction in patients with psoriasis. JAMA (2006) 9.42
Financial incentive-based approaches for weight loss: a randomized trial. JAMA (2008) 7.01
American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc (2010) 6.18
A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med (2009) 6.08
A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med (2011) 5.98
Phase II trial of sorafenib in advanced thyroid cancer. J Clin Oncol (2008) 5.31
An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv (2010) 4.73
Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol (2006) 4.12
Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J (2009) 3.93
Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation (2005) 3.28
The risk of stroke in patients with psoriasis. J Invest Dermatol (2009) 2.97
The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol (2010) 2.90
Functional limitations in elderly female cancer survivors. J Natl Cancer Inst (2006) 2.89
Plantar Fasciitis: What's an Evidence-Informed Consumer to Do? Physiother Can (2008) 2.61
Individual- versus group-based financial incentives for weight loss: a randomized, controlled trial. Ann Intern Med (2013) 2.59
Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol (2011) 2.36
The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol (2007) 2.32
A systematic review of the effectiveness of exercise, manual therapy, electrotherapy, relaxation training, and biofeedback in the management of temporomandibular disorder. Phys Ther (2006) 2.31
Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol (2006) 2.27
A test of financial incentives to improve warfarin adherence. BMC Health Serv Res (2008) 2.23
Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study. J Clin Oncol (2008) 2.19
Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting. Arch Dermatol (2012) 2.19
Comparison of two approaches to structured physical activity surveys for adolescents. Med Sci Sports Exerc (2004) 2.19
The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus. Arch Dermatol (2008) 2.17
The metabolic syndrome and risk of incident colorectal cancer. Cancer (2006) 2.16
Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med (2011) 2.16
Financial incentives for extended weight loss: a randomized, controlled trial. J Gen Intern Med (2011) 2.07
Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Carcinogenesis (2008) 2.03
Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer. J Clin Oncol (2008) 2.02
An index of local sensitivity to nonignorable drop-out in longitudinal modelling. Stat Med (2005) 2.00
A Propensity-Matched Analysis of the Influence of Breast Reconstruction on Subsequent Development of Lymphedema. Plast Reconstr Surg (2015) 1.97
Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med (2011) 1.94
Lack of association of physical activity and obesity with incident pancreatic cancer in elderly women. Cancer Epidemiol Biomarkers Prev (2005) 1.92
Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study. Arch Surg (2010) 1.91
Reliability and convergent validity of two outcome instruments for pemphigus. J Invest Dermatol (2009) 1.88
Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA (2010) 1.83
Health care communication issues in multiple sclerosis: an interpretive description. Qual Health Res (2004) 1.83
Immunosuppressant medications and mortality in inflammatory bowel disease. Am J Gastroenterol (2008) 1.80
Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer (2005) 1.78
The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev (2012) 1.75
Sleep duration and adolescent obesity. Pediatrics (2013) 1.75
Quality of life and symptom burden among long-term lung cancer survivors. J Thorac Oncol (2012) 1.74
School-level intraclass correlation for physical activity in adolescent girls. Med Sci Sports Exerc (2004) 1.73
A retrospective case-control study of the use of hormone-related supplements and association with breast cancer. Int J Cancer (2007) 1.71
Objectively measured physical activity in sixth-grade girls. Arch Pediatr Adolesc Med (2006) 1.70
Travel by walking before and after school and physical activity among adolescent girls. Arch Pediatr Adolesc Med (2007) 1.69
Implementing the exercise guidelines for cancer survivors. J Support Oncol (2012) 1.66
Diffuse optical measurement of blood flow in breast tumors. Opt Lett (2005) 1.65
Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol (2013) 1.64
The risk of lymphoma in patients with psoriasis. J Invest Dermatol (2006) 1.62
Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology. Cancer Epidemiol Biomarkers Prev (2007) 1.62
Quality of life after breast cancer surgery: What have we learned and where should we go next? J Surg Oncol (2009) 1.60
The effects of neighborhood density and street connectivity on walking behavior: the Twin Cities walking study. Epidemiol Perspect Innov (2007) 1.59
The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol (2011) 1.59
Variation in receipt of opioids by pediatric oncology patients who died in children's hospitals. Pediatr Blood Cancer (2009) 1.56
Major cardiovascular events associated with anti-IL 12/23 agents: a tale of two meta-analyses. J Am Acad Dermatol (2013) 1.49
Regional and racial disparities in breast cancer-specific mortality. Soc Sci Med (2005) 1.43
Physical activity in young adults and incident hypertension over 15 years of follow-up: the CARDIA study. Am J Public Health (2007) 1.42
Challenges in trying to implement an early intervention program for infants with congenital heart disease. Pediatr Phys Ther (2015) 1.41
Physical inactivity: direct cost to a health plan. Am J Prev Med (2004) 1.40
Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. J Natl Cancer Inst (2006) 1.39
Agreement Between a Physical Therapist and an Orthopedic Surgeon in Children Referred for Gait Abnormalities. Pediatr Phys Ther (2016) 1.38
Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis. Arch Dermatol (2012) 1.37
Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. Cancer (2012) 1.36
Effects of weight training on quality of life in recent breast cancer survivors: the Weight Training for Breast Cancer Survivors (WTBS) study. Cancer (2006) 1.35
Weekend and weekday patterns of physical activity in overweight and normal-weight adolescent girls. Obesity (Silver Spring) (2007) 1.33
Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. Clin Ther (2008) 1.32
Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines. Cancer Epidemiol Biomarkers Prev (2006) 1.30
Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases. Clin Cancer Res (2009) 1.30
Outcomes of a weight loss intervention among rural breast cancer survivors. Breast Cancer Res Treat (2011) 1.29
Changes in the Body Image and Relationship Scale following a one-year strength training trial for breast cancer survivors with or at risk for lymphedema. Breast Cancer Res Treat (2009) 1.28
Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. Am J Epidemiol (2006) 1.27
Physical Activity and Lymphedema (the PAL trial): assessing the safety of progressive strength training in breast cancer survivors. Contemp Clin Trials (2009) 1.27
Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study. Breast Cancer Res Treat (2011) 1.26
The 2011-2016 Transdisciplinary Research on Energetics and Cancer (TREC) initiative: rationale and design. Cancer Causes Control (2013) 1.26
Women in Steady Exercise Research (WISER): study design and methods. Contemp Clin Trials (2010) 1.25
Parenchymal texture analysis in digital breast tomosynthesis for breast cancer risk estimation: a preliminary study. Acad Radiol (2009) 1.24
Development of the CLASI as a tool to measure disease severity and responsiveness to therapy in cutaneous lupus erythematosus. Arch Dermatol (2011) 1.23
Effect of exercise on oxidative stress: a 12-month randomized, controlled trial. Med Sci Sports Exerc (2010) 1.22
Preventing overestimation of pixels in computed tomography assessment of visceral fat. Obes Res (2004) 1.22
Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer. Cancer (2012) 1.22
Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis. J Am Acad Dermatol (2012) 1.21
A prospective surveillance model for rehabilitation for women with breast cancer. Cancer (2012) 1.21
Factors impacting the departure rates of female and male junior medical school faculty: evidence from a longitudinal analysis. J Womens Health (Larchmt) (2012) 1.19
Randomized trial of lottery-based incentives to improve warfarin adherence. Am Heart J (2012) 1.19
Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients. J Am Acad Dermatol (2011) 1.18
Barriers to minority participation in breast carcinoma prevention trials. Cancer (2005) 1.18
Breast percent density: estimation on digital mammograms and central tomosynthesis projections. Radiology (2009) 1.17
Polycyclic aromatic hydrocarbon (PAH) o-quinones produced by the aldo-keto-reductases (AKRs) generate abasic sites, oxidized pyrimidines, and 8-oxo-dGuo via reactive oxygen species. Chem Res Toxicol (2006) 1.15
Formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dGuo) by PAH o-quinones: involvement of reactive oxygen species and copper(II)/copper(I) redox cycling. Chem Res Toxicol (2005) 1.15
Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer. Cancer (2012) 1.15
The context of health care communication in chronic illness. Patient Educ Couns (2004) 1.14
Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study. Dermatol Surg (2009) 1.14
Quality of life and disease severity in a cutaneous lupus erythematosus pilot study. Arch Dermatol (2008) 1.13
Effect of team sport participation on genetic predisposition to adolescent smoking progression. Arch Gen Psychiatry (2006) 1.12
Associations of body size and composition with physical activity in adolescent girls. Med Sci Sports Exerc (2006) 1.12
School-level intraclass correlation for physical activity in sixth grade girls. Med Sci Sports Exerc (2006) 1.12